期刊文献+

结直肠癌与人组织激肽释放酶关系的研究进展 被引量:1

下载PDF
导出
摘要 全球每年死于结直肠癌的患者约为50万,新诊断病例约100万。如何降低结直肠癌的病死率成为当前呕待解决的问题。在过去的几年里,结直肠癌的总发病率和病死率有所降低,这主要归功于新增血清肿瘤标志物的检查[如癌胚抗原(CEA)和糖类抗原199(CA199)]、内镜检查技术和疾病医疗技术的提高等。如何借助最新分子生物学技术,寻找有关结直肠癌早期诊断、预后监测的新指标是当前结直肠癌研究中至关重要的问题。
出处 《国际检验医学杂志》 CAS 2014年第19期2658-2661,共4页 International Journal of Laboratory Medicine
  • 引文网络
  • 相关文献

参考文献30

  • 1Mccracken M,Olsen M, Chen MS, et al. Cancer incidence,mortali- ty, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean and Japanese ethnicities [ J ]. CA Cancer J Clin,2007,57(4) : 190-205.
  • 2Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 3Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs) : a gene family of novel cancer biomarkers[J]. Clin Chem Lab Med, 2012,50(11) : 1877-1891.
  • 4Yousef GM,Diamandis EP. The new human tissue kallikrein gene family., structure, function and association to disease[J]. Endocr Rev, 2001,22(2) : 184-204.
  • 5Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer[J]. Nat Rev Cancer,2004,4(11) :876-890.
  • 6Jin E, Fujiwara M, Pan X, et al. Protease-activated receptor(PAR)-I and PAR-2 participate in the cell growth of alveolar capillary endothe- lium in primary lung adenocarcinomas[J] Cancer, 2003,97 ( 3 ) : 703- 713.
  • 7Bay,s A,Tsetsenis T,Ventura S,et al. Human kallikrein 6 activi- ty is regulated via an autoproteolytic mechanism of activation/in- activation[J]. Biol Chem,2004,385(6) :517-524.
  • 8Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids [J]. Clin Chem, 2007,53 (8) : 1423- 1432.
  • 9Gratio V, Beaufort N, Seiz L, et al. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated re- ceptor 1 in colon cancer cells[J]. Am J Pathol, 2010, 176 (3): 1452-1461.
  • 10Kontos CK, Chantzis D,Papadopoulos IN, et al. Kallikrein-related peptidase 4(KLK4)mRNA predicts short-term relapse in colorec- tal adenocarcinoma patients[J]. Cancer Lett, 2013,330 ( 1 ) : 106- 112.

二级参考文献49

  • 1胡成进,沈茜,陈英剑,闻新棉.乳腺癌klk6基因表达的实时荧光定量法的建立及初步应用[J].中华检验医学杂志,2005,28(6):610-612. 被引量:10
  • 2冯波,郑民华,马君俊,蔡劬,张轶,计骏,瞿颖,李健文,陆爱国,王明亮,刘炳亚,朱正纲.结直肠癌组织中激肽释放酶10基因的表达及其与临床及病理的关系[J].中华外科杂志,2006,44(9):623-627. 被引量:5
  • 3Borgono CA, Diamandis EP.The emerging roles of human kallikreins in cancer[J]. Nat Rev Cancer, 2004,4( 11 ) : 876.
  • 4Paliouras M, Borgono CA, Diamandis EP. Human tissue kallikreins: The cancer biomarker family [ J ]. Caneter lett, 2007,249 ( 1 ) :61.
  • 5Yousef GM, Scorilas A, Kyfiakopoulcu LG, et al. Human kallikrein gene 5 (KIXS) expression by quantiative PCR: An independent indicator of poor progenosis in breast cancer[J]. Clin Chem,2002,48(8) : 1241.
  • 6Yousef GM, Polymeris ME, Grass L, et al. Human kallikrein 5 : A potential novel serum biomarker for breast and ovarian cancer [ J ]. Cancer Res, 2003,63(14) :3958.
  • 7Yousef GM, Scorilas A, Chang A, et al. Down-regulation of the human kallikrein gene5 (KLK5) in prostate cancer tissues[J].The Prostate, 2002,51(2):126.
  • 8Yonsef GM, Obiezu CV, Jung K, et al. Differential expression of Kallikrein gone 5 in cancerous and normal testicular tissues[J]. Urology 2002,60 (4) :714.
  • 9Planque C,de Monte M, Guyetant S,et al. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer[J]. Biochem Biophys Res Commun,2005,329(4) : 1260.
  • 10Rasmussen R. Quantification on the Light Cycler. Rapid Cycle Real-time PCR, Methods and Applications [ M ]. Springer Press, Heidelberg; 2001.21.

共引文献5

同被引文献7

引证文献1

二级引证文献3

相关主题

;
使用帮助 返回顶部